Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whether Controlling Serum Uric Acid (SUA) Can Benefit Postoperative Survival in Patients With Pancreatic Cancer

NCT07091526 is registered in ClinicalTrials.gov with Hepatopancreatobiliary Surgery Institute of Gansu Province as lead sponsor.

NCT NCT07091526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07091526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whether Controlling Serum Uric Acid (SUA) Can Benefit Postoperative Survival in Patients With Pancreatic Cancer
Lead sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Phase
Observational
Overall status
Recruiting
Start date
July 29, 2025
Completion date
December 29, 2026
Enrollment
168 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

serum uric acid